Find NINDS Clinical Trials

Study Title Disorders Status Study Location Clinical Trials ID
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Multiple Sclerosis Completed Maryland NCT00001669
50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease Completed Maryland NCT00977184
5-Cog Battery for Detecting Cognitive Impairment and Dementia Dementias Recruiting New York NCT03816644
5-Cog 2.0: A Pragmatic Clinical Trial Dementias Not Yet Recruiting Multiple U.S. Locations NCT05515224
4-AP Peripheral Nerve Crossover Trial Not Yet Recruiting NCT06003166
3-D Tractography FUS Ablation for Essential Tremor Essential Tremor Recruiting North Carolina NCT06331052
1-Octanol to Treat Essential Tremor Essential Tremor Completed Maryland NCT00016679
1-Octanol to Treat Essential Tremor Essential Tremor Completed Maryland NCT00001986